Viewing StudyNCT00062686



Ignite Creation Date: 2024-05-05 @ 11:31 AM
Last Modification Date: 2024-10-26 @ 9:08 AM
Study NCT ID: NCT00062686
Status: COMPLETED
Last Update Posted: 2015-04-15
First Post: 2003-06-11

Brief Title: GW572016 For Treatment Of Refractory Metastatic Breast Cancer
Sponsor: GlaxoSmithKline
Organization: GlaxoSmithKline

Conditions & Keywords Data

Conditions:
Name
Neoplasms Breast
Keywords:
Name View
HERCEPTIN refractory View
Lapatinib View
Metastatic Breast Cancer View